Arber, 2016, The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood, 127, 2391, 10.1182/blood-2016-03-643544
Barosi, 2008, International Working Group for Myeloproliferative neoplasms Research and Treatment (IWG-MRT), 22, 437
Tefferi, 2014, Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis, Blood., 124, 2507, 10.1182/blood-2014-05-579136
Tam, 2008, The natural history and treatment outcome of blast phase BCR-ABL- myeloprolifeerative neoplasms, Blood, 112, 1628, 10.1182/blood-2008-02-138230
Holcombe, 1991, Chronic myelomonocytic leukemia transformation in polycythemia vera, Leukemia, 5, 606
Barraco, 2017, Monocytosis in polycythemia vera: clinical and molecular correlates, Am. J. Hematol., 92, 640, 10.1002/ajh.24740
James, 2005, A unique clonal JAK2 mutation leading to constitutive signaling causes polycythemia vera, Nature, 434, 1144, 10.1038/nature03546
Nangalia, 2013, Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2, N Engl J Med, 369, 2391, 10.1056/NEJMoa1312542
Arber, 2016, The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood, 127, 2391, 10.1182/blood-2016-03-643544
Wong, 2011, Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets, Blood., 118, e16, 10.1182/blood-2010-12-326355
Talati, 2016, Monocytes subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosis, Blood, 128, 2009, 10.1182/blood.V128.22.2009.2009
Finazzi, 2005, Acute leukemia in polycythemia vera. An analysis of 1638 patients enrolled in a prospective observational study, Blood, 105, 2664, 10.1182/blood-2004-09-3426
Passamonti, 2008, A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis, Blood, 111, 3383, 10.1182/blood-2007-11-121434
Lopez, 2016, Cytogenetic abnormalities may predict transformation to acute myeloid leukemia in polycythemia vera patients, Blood, 128, 4258, 10.1182/blood.V128.22.4258.4258
Levine, 2005, The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia, Blood., 106, 3377, 10.1182/blood-2005-05-1898
Xu, 2013, Chronic myelomonocytic leukemia with preexisting myelodysplastic syndrome or myeloproliferative neoplasm: two stages of one disease with poor prognosis, Blood, 122, 1342, 10.1182/blood.V122.21.1342.1342
Takahashi, 2013, Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia, Blood, 122, 2807, 10.1182/blood-2013-03-491399